Mesoblast Ltd Files Quarterly Report
Ticker: MEOBF · Form: 6-K · Filed: Jan 31, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Jan 31, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: quarterly-report, sec-filing, biotech
TL;DR
MESO dropped a quarterly update, check the Appendix 4C for deets.
AI Summary
On January 31, 2025, Mesoblast Limited filed a quarterly Appendix 4C report with the Australian Securities Exchange. This report covers the period ending January 31, 2025, and is filed as a Form 6-K with the SEC. The company is incorporated in Australia and its CEO is Silviu Itescu.
Why It Matters
This filing provides an update on Mesoblast's financial and operational activities for the past quarter, which is crucial for investors to assess the company's progress and financial health.
Risk Assessment
Risk Level: low — This is a routine quarterly filing and does not contain significant new financial or strategic information that would immediately alter the company's risk profile.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- January 31, 2025 (date) — Filing date of quarterly report
FAQ
What type of report did Mesoblast Limited file on January 31, 2025?
Mesoblast Limited filed a quarterly report for entities admitted on the basis of commitments (Appendix 4C) with the Australian Securities Exchange.
What is the Commission File Number for Mesoblast Limited?
The Commission File Number for Mesoblast Limited is 001-37626.
Who is the CEO and Executive Director of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Where is Mesoblast Limited's principal executive office located?
Mesoblast Limited's principal executive office is located at Level 38, 55 Collins Street, Melbourne 3000, Australia.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited files annual reports under Form 20-F.
Filing Stats: 269 words · 1 min read · ~1 pages · Grade level 14.9 · Accepted 2025-01-30 20:50:21
Filing Documents
- a2025-01x31appendix4cupdate.htm (6-K) — 22KB
- exhibit991.htm (EX-99.1) — 26KB
- exhibit992.htm (EX-99.2) — 20KB
- exhibit991001.jpg (GRAPHIC) — 231KB
- exhibit991002.jpg (GRAPHIC) — 297KB
- exhibit991003.jpg (GRAPHIC) — 156KB
- exhibit991004.jpg (GRAPHIC) — 117KB
- exhibit991005.jpg (GRAPHIC) — 127KB
- exhibit991006.jpg (GRAPHIC) — 175KB
- exhibit991007.jpg (GRAPHIC) — 186KB
- exhibit991008.jpg (GRAPHIC) — 156KB
- exhibit991009.jpg (GRAPHIC) — 116KB
- exhibit992001.jpg (GRAPHIC) — 204KB
- exhibit992002.jpg (GRAPHIC) — 253KB
- exhibit992003.jpg (GRAPHIC) — 274KB
- exhibit992004.jpg (GRAPHIC) — 283KB
- exhibit992005.jpg (GRAPHIC) — 174KB
- 0001345099-25-000006.txt ( ) — 3856KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated January 31, 2025 INDEX TO EXHIBITS Item 99.1 Appendix 4C of Mesoblast Ltd, dated January 31, 2025 . 99.2 Press release of Mesoblast Ltd, dated January 31, 2025.